本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Oncolytics Biotech Inc

1.06
-0.0200-1.85%
盘后1.05-0.0100-0.94%16:47 EDT
成交量:26.99万
成交额:28.65万
市值:1.07亿
市盈率:-3.92
高:1.10
开:1.09
低:1.05
收:1.08
52周最高:1.53
52周最低:0.3258
股本:1.01亿
流通股本:9,362.53万
量比:0.26
换手率:0.29%
股息:- -
股息率:- -
每股收益(TTM):-0.2701
每股收益(LYR):-0.2881
净资产收益率:-249.28%
总资产收益率:-74.56%
市净率:24.37
市盈率(LYR):-3.68

数据加载中...

2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]